The Supporting Patient Activation in Transition to Home Intervention ([sPATH])

September 20, 2020 updated by: Mirjam Ekstedt, Karolinska Institutet

The Supporting Patient Activation in Transition to Home (sPATH) Intervention - a Study Protocol of Randomized Controlled Trial

This study evaluates if motivational interviewing sessions aiming to motivate recently discharged patients with either chronic obstructive pulmonary disease or congestive heart failure to be active in post-discharge self-management can reduce re-hospitalization rates.

Study Overview

Detailed Description

Included patients transition to home will be bridged through a telephone-call from a patient activation coach two days post-discharge. The patients will thereafter get motivational interviewing sessions by the same patient activation coach with the the goal that the patients are motivated to the knowledge, skills and confidence needed to manage the four main activity areas: 1) medication management; 2) adhere to care plan/ follow-up visits according to the discharge plan; 3) recognize indications (symptoms/signs) that the condition is worsening and how to respond; and 4) contact and manage relations/encounters with health care providers. Patients in control group will receive standard care, i.e. discharge and follow-up as in normal procedures. The investigators will use a randomization in permuted blocks of 10 intervention patients and 10 control patients included. To test the hypothesis that the re-hospitalizations rate is 15 % lower in the intervention group compared to the control group 242 patients (121 per group) are needed for power of 80% with the level of significance set to 5 % using two-sided chi-square.

Study Type

Interventional

Enrollment (Actual)

118

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Huddinge, Sweden
        • Akutkliniken, Karolinska University Hospital
      • Huddinge, Sweden
        • Karolinska Universitetssjukhuset, Lung- Allergikliniken

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients aged 18 years or older with chronic obstructive pulmonary disease or congestive heart failure admitted at a short-term medical ward and who are living in their private home.

Exclusion Criteria:

  • Diagnoses of dementia or cognitive impairment, and need of interpreter to participate in conversations.

The exclusion criteria are related to the patients' possibilities to participate in the motivational interviewing sessions by phone.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: Control
Care as usual
EXPERIMENTAL: sPATH
Motivational Interviewing in five sessions post hospital discharge
Patients will get motivational interviewing sessions by a patient activation coach (medical social workers and/or nurses trained in motivational interviewing and in the intervention) in five post hospital discharge sessions (whereof one face-to-face, four by phone) aiming to increase patient motivation to become active in self-management (medication management, care plan/follow-up, symptoms/signs of worsening condition, contacts with health care provider).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Re-hospitalization
Time Frame: 90 days
Registry data from the Swedish Register for Health Care Encounters
90 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Healthcare usage
Time Frame: 30, 90 and 180 days
Registry data from the Swedish Register for Health Care Encounters: re-hospitalization at 30 and 180 days. Emergency room and primary care visits at 30, 90 and 180 days
30, 90 and 180 days
Medication adherence
Time Frame: 30, 90 and 180 days
Patient reported data using the Morisky Medication Adherence Scale, 8 items, and registry data using medicine data from the Swedish Prescribed Drug Registry
30, 90 and 180 days
Patient activation
Time Frame: 30, 90 and 180 days
Patient reported data using the Patient Activation Measure, 13 item
30, 90 and 180 days
Health related quality of life
Time Frame: 30, 90 and 180 days
Patient reported data using the EQ-5D-5L
30, 90 and 180 days
Basic Psychological Needs
Time Frame: 30, 90 and 180 days
Patient reported data using the the Basic Psychological Need Satisfaction & Frustration Scale, 18 items
30, 90 and 180 days
Depression
Time Frame: 30, 90 and 180 days
Patient reported data using PHQ-9 (Patient Health Questionnaire)
30, 90 and 180 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Mirjam Ekstedt, Professor, LIME, Karolinska Institutet

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 1, 2016

Primary Completion (ACTUAL)

June 30, 2018

Study Completion (ACTUAL)

September 1, 2018

Study Registration Dates

First Submitted

July 1, 2016

First Submitted That Met QC Criteria

July 5, 2016

First Posted (ESTIMATE)

July 6, 2016

Study Record Updates

Last Update Posted (ACTUAL)

September 23, 2020

Last Update Submitted That Met QC Criteria

September 20, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • C751231003
  • Dnr 2014-0026 (OTHER_GRANT: Vårdalsstiftelsen)
  • Dnr 2014-4948 (OTHER_GRANT: Forte)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Clinical Trials on Motivational Interviewing

Subscribe